Periodic Medical Review Package in Lahore at Chughtai Lab

Periodic Medical Review at Chughtai Lab

The Periodic Medical Review at Chughtai Lab is a comprehensive, evidence-based preventive health screening program designed to systematically evaluate an individual’s overall physiological status. In modern clinical practice, the transition from reactive treatment to proactive wellness is essential for mitigating the burden of chronic, non-communicable diseases. This structured medical evaluation serves as a cornerstone of preventive medicine, offering a detailed assessment of vital organ systems, metabolic pathways, and hematological profiles. By identifying subclinical physiological changes before clinical symptoms manifest, this review empowers patients and clinicians to implement timely lifestyle modifications or therapeutic interventions, significantly improving long-term health outcomes.

Utilizing state-of-the-art laboratory technology, the Periodic Medical Review at Chughtai Lab analyzes multiple biological markers. The evaluation encompasses a broad spectrum of diagnostic tests, including a complete blood count (CBC) to assess the hematopoietic system, a comprehensive lipid profile to evaluate cardiovascular risk, renal function tests (RFTs) to monitor kidney health, liver function tests (LFTs) to assess hepatic metabolic and excretory capacity, and blood glucose monitoring to evaluate carbohydrate metabolism. This multi-system approach ensures that potential health risks—such as silent cardiovascular disease, early-stage renal impairment, metabolic syndrome, prediabetes, and hepatic steatosis—are identified early in their natural history.

The diagnostic value of a periodic medical review lies in its ability to establish an individual’s personalized physiological baseline. Every human body possesses unique metabolic and biochemical characteristics; having a documented history of these parameters allows healthcare providers to detect subtle, longitudinal deviations that might otherwise go unnoticed. This is particularly critical for individuals with a family history of hereditary conditions, such as essential hypertension, type 2 diabetes mellitus, ischemic heart disease, or chronic kidney disease. Through the extensive network of Chughtai Lab across Pakistan, patients have access to highly standardized, quality-controlled testing that meets international benchmarks, ensuring that every result is clinically actionable and highly reliable.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost clinical accuracy and reproducibility of the test results within the Periodic Medical Review, patients must adhere strictly to the following preparation guidelines:

• Mandatory Fasting: Patients must undergo a strict overnight fast of 10 to 12 hours prior to sample collection. During this fasting period, no food, juices, tea, coffee, or sodas should be consumed. Only plain, unflavored water is permitted and highly encouraged to maintain adequate hydration.
• Medication Management: Patients should consult their prescribing physician regarding their routine morning medications. Generally, essential cardiovascular or antihypertensive medications can be taken with water, but diabetic medications should typically be held until after the blood draw to prevent hypoglycemia.
• Avoid Alcohol and Tobacco: Consumption of alcohol and tobacco products should be avoided for at least 24 to 48 hours before the test, as these substances can acutely alter liver enzyme levels, lipid fractions, and blood glucose concentrations.
• Physical Activity: Strenuous physical exercise or intense workouts should be avoided for 24 hours prior to the blood draw, as intense exertion can transiently elevate muscle enzymes (such as creatine kinase) and alter renal function parameters.
• Urine Sample Collection: For the urinalysis component, patients will be provided with a sterile container. It is critical to collect a “midstream clean-catch” urine sample to minimize contamination from external skin flora.

During the Procedure

The clinical procedure for the Periodic Medical Review at Chughtai Lab is streamlined, hygienic, and designed to minimize patient discomfort while maintaining the highest standards of biosafety:

• Patient Identification and Verification: Upon arrival, the phlebotomist verifies the patient’s identity using dual identifiers (name and registration number) and reviews the clinical request to ensure all pre-analytical requirements (such as fasting status) are met.
• Phlebotomy Setup: The patient is seated comfortably in a specialized phlebotomy chair. The phlebotomist prepares sterile, single-use vacuum tubes (vacutainers) color-coded for specific tests (e.g., lavender top for CBC, red/gold top for serum chemistry).
• Venipuncture: A tourniquet is applied to the upper arm to locate a suitable vein, typically the median cubital vein. The site is thoroughly sanitized with an isopropyl alcohol swab and allowed to air dry. A sterile, high-gauge needle is inserted, and blood is drawn into the appropriate tubes using a closed vacuum system.
• Post-Draw Care: Once the required volume of blood is collected, the needle is gently withdrawn, and immediate manual pressure is applied to the puncture site with a sterile gauze pad to prevent hematoma formation. A sterile adhesive bandage is then applied.
• Urine Collection: The patient is directed to the restroom to collect the midstream urine sample in the provided sterile container, which is then immediately labeled with the patient’s unique barcode.
• Duration and Safety: The entire collection process is completed within 10 to 15 minutes. Chughtai Lab strictly adheres to international biosafety guidelines, utilizing only single-use, disposable materials to eliminate any risk of cross-contamination.

When is a Periodic Medical Review Performed?

Screening for Cardiovascular Risk Factors

Physicians frequently request a Periodic Medical Review to screen for silent cardiovascular risk factors in asymptomatic individuals. Cardiovascular diseases, including coronary artery disease and myocardial infarction, often develop silently over decades. By evaluating the comprehensive lipid profile—including total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides—clinicians can calculate cardiovascular risk scores and implement lipid-lowering therapies or dietary interventions before clinical events occur.

Early Detection of Type 2 Diabetes and Metabolic Syndrome

With the rising prevalence of metabolic disorders in Pakistan, early detection of impaired glucose tolerance is critical. The fasting blood glucose and glycated hemoglobin (HbA1c) components of the review allow physicians to identify prediabetes and early-stage type 2 diabetes. Detecting these metabolic shifts early enables patients to reverse insulin resistance through structured lifestyle modifications, thereby preventing long-term microvascular and macrovascular complications.

Assessment of Renal and Hepatic Function

Chronic kidney disease (CKD) and non-alcoholic fatty liver disease (NAFLD) are highly prevalent and often remain entirely asymptomatic in their early stages. A Periodic Medical Review evaluates serum creatinine, urea, estimated glomerular filtration rate (eGFR), and key liver enzymes (ALT, AST, ALP). This allows for the early detection of renal parenchymal decline or hepatic inflammation, prompting lifestyle adjustments, medication reviews, or specialist referrals to prevent progressive organ damage.

Monitoring Hematological Health and Anemia

Anemia is a widespread public health concern that causes chronic fatigue, cognitive decline, and decreased physical productivity. Through the Complete Blood Count (CBC) component of the review, clinicians can evaluate red blood cell indices, hemoglobin concentration, and hematocrit. This helps in diagnosing various forms of anemia (such as iron deficiency or vitamin B12 deficiency) and identifying underlying chronic inflammatory processes or hematological disorders.

Routine Occupational and Annual Health Surveillance

Many corporate organizations, high-risk industries, and health-conscious individuals utilize the Periodic Medical Review as an annual health surveillance tool. It is performed to ensure employees are physically fit for their specific roles, monitor the health of individuals exposed to occupational hazards, and provide peace of mind to individuals who wish to maintain a proactive, structured approach to their personal health and longevity.

What Does a Periodic Medical Review Detect?

The Periodic Medical Review is designed to detect a wide array of subclinical abnormalities, metabolic shifts, and early-stage diseases, including:

• Iron Deficiency Anemia: Characterized by low hemoglobin, low hematocrit, and microcytic, hypochromic red blood cell indices.
• Megaloblastic Anemia: Indicated by elevated mean corpuscular volume (MCV), often associated with Vitamin B12 or folate deficiency.
• Infectious or Inflammatory Processes: Detected via elevated white blood cell (WBC) counts or shifts in the differential leukocyte count.
• Thrombocytopenia: Abnormally low platelet counts, which can increase the risk of spontaneous bleeding or bruising.
• Hypercholesterolemia: Elevated total cholesterol levels, a key risk factor for systemic atherosclerosis.
• Atherogenic Dyslipidemia: Elevated low-density lipoprotein (LDL) and decreased high-density lipoprotein (HDL) levels.
• Hypertriglyceridemia: Elevated serum triglycerides, associated with metabolic syndrome and acute pancreatitis when extremely high.
• Impaired Fasting Glucose: Blood glucose levels that are higher than normal but not yet in the diabetic range (prediabetes).
• Type 2 Diabetes Mellitus: Confirmed by fasting plasma glucose levels exceeding established diagnostic thresholds.
• Impaired Glomerular Filtration: Detected via decreased eGFR, indicating early-stage chronic kidney disease.
• Renal Azotemia: Elevated levels of blood urea nitrogen (BUN) and serum creatinine, suggesting impaired waste excretion.
• Hyperuricemia: Elevated serum uric acid levels, which can lead to gouty arthritis or renal calculi.
• Hepatic Steatosis / Fatty Liver: Suggested by isolated elevations in alanine aminotransferase (ALT) and aspartate aminotransferase (AST).
• Cholestatic Liver Disease: Indicated by elevated alkaline phosphatase (ALP) and bilirubin levels, suggesting biliary impairment.
• Hypothyroidism: Detected via elevated Thyroid Stimulating Hormone (TSH) levels, indicating underactive thyroid function.
• Hyperthyroidism: Indicated by suppressed TSH levels, pointing to thyroid hormone excess.
• Urinary Tract Infection (UTI): Detected via urinalysis showing the presence of leucocytes, nitrites, and bacteria.
• Microscopic Hematuria: The presence of red blood cells in the urine, requiring further investigation for renal stones or urothelial pathology.
• Proteinuria / Albuminuria: The presence of protein in the urine, an early indicator of diabetic nephropathy or hypertensive renal damage.
• Glucosuria: Glucose excretion in the urine, typically occurring when blood glucose levels exceed the renal threshold.
• Electrolyte Imbalances: Abnormal levels of sodium, potassium, or chloride, which can affect cardiac conduction and fluid balance.
• Subclinical Systemic Inflammation: Indicated by non-specific markers that prompt further diagnostic investigation.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is widely recognized for its highly efficient laboratory workflow and rapid turnaround times. For standard Periodic Medical Review packages, results are typically processed, verified by a consultant pathologist, and ready for release within 12 to 24 hours of sample collection. Once the diagnostic reports are finalized, patients receive an automated SMS notification containing a secure direct link to view and download their electronic reports.

In addition to digital delivery, patients can access their complete diagnostic history online through the official Chughtai Lab website by entering their unique Patient ID and password printed on the registration receipt. For enhanced convenience, the Chughtai Healthcare Mobile App is available on both iOS and Android platforms, allowing patients to track their health trends over time, download PDF reports, and share them directly with their primary care physicians. Physical copies of the reports can also be collected from any of the numerous Chughtai Lab collection centers located nationwide.

Periodic Medical Review Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Complete Blood Count (CBC)	Normal hemoglobin, hematocrit, WBC, and platelet counts within reference ranges.	Anemia, leukocytosis, leukopenia, thrombocytopenia, or microcytosis.
Fasting Blood Glucose	70 to 99 mg/dL (Normal fasting glycemic control).	100 to 125 mg/dL (Prediabetes); ≥ 126 mg/dL (Suspected Diabetes).
Lipid Profile (LDL / HDL)	LDL < 100 mg/dL; HDL > 40 mg/dL (males) or > 50 mg/dL (females).	Elevated LDL (hypercholesterolemia); low HDL (increased cardiovascular risk).
Kidney Function (Creatinine & eGFR)	Serum Creatinine within age/gender norms; eGFR ≥ 90 mL/min/1.73 m².	Elevated creatinine; eGFR < 60 mL/min/1.73 m² (suggestive of renal impairment).
Liver Function (ALT / SGPT)	ALT within standard laboratory reference limits (typically < 50 U/L).	Elevated ALT/AST (indicative of hepatocellular injury or fatty liver).
Thyroid Stimulating Hormone (TSH)	0.4 to 4.0 mIU/L (Euthyroid state).	Elevated TSH (Hypothyroidism); suppressed TSH (Hyperthyroidism).
Urinalysis (Protein & Glucose)	Negative for protein, glucose, ketones, blood, and nitrites.	Proteinuria (renal damage); glucosuria (diabetes); hematuria or pyuria (UTI/stones).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Periodic Medical Review?

• CAP Accreditation: Chughtai Lab is accredited by the College of American Pathologists (CAP), ensuring adherence to the highest international quality standards in laboratory medicine.
• Advanced Automation: The laboratory utilizes state-of-the-art, fully automated analytical platforms from world-leading diagnostic manufacturers, minimizing human error.
• Expert Pathologists: All complex panels and abnormal findings are reviewed and verified by highly qualified, board-certified Consultant Pathologists.
• Nationwide Network: With over 300 collection centers across Pakistan, patients can easily access diagnostic services in almost every major city.
• Convenient Home Sample Collection: Chughtai Lab offers professional, temperature-controlled home sample collection services, bringing healthcare directly to your doorstep.
• Seamless Digital Access: Patients can view, download, and archive their medical reports via the user-friendly Chughtai Healthcare Mobile App or official website.
• Rigorous Quality Control: The lab participates in extensive internal and external quality assurance programs to maintain unmatched testing accuracy.
• Holistic Healthcare Ecosystem: Beyond diagnostics, Chughtai Healthcare offers integrated services including pharmacies, primary care clinics, and home care services.